Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains
Preventive therapy for drug-resistant TB, including fluoroquinolone-resistant strains, is acceptable, safe, and effective. Implementation of comprehensive TPT programs in high-burden DR-TB settings can protect contacts and reduce transmission.
Authors
- Grigory Volchenkov (ORCID: https://orcid.org/0000-0002-3416-6477)
- Einar Heldal (ORCID: https://orcid.org/0000-0002-8741-792X)
- Alexandra V. Solovyeva
- Sven Gudmund Hinderaker (ORCID: https://orcid.org/0000-0003-2725-0248)
- Salmaan Keshavjee (ORCID: https://orcid.org/0000-0002-6967-3305)
- Tatiana R. Somova
- O. Ponomarenko
- Tatiana A. Kuznezova
- Evgenia V Belova
Institutions
- Brigham and Women's Hospital (US)
- Partners In Health (US)
- Lovisenberg Diakonale Høgskole (NO)
- Vladimir State University (RU)
- Scientific Research Institute of Healthcare Organization and Medical Management (RU)
- Vladimir Law Institute (RU)
- Harvard Global Health Institute (US)
- Vladimir Institute of Business (RU)
- University of Bergen (NO)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1093/cid/ciaf701
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00